Authors' reply to Fell

Shai Mulinari; Piotr Ozieranski

doi:10.1136/bmj.p2493

Authors' reply to Fell

Shai Mulinari
, Piotr Ozieranski

Lund University
University of Queensland
University of London

Research output: Contribution to journal › Letter

Original language	English
Pages (from-to)	2493
Number of pages	1
Journal	BMJ (Clinical research ed.)
Volume	383
DOIs	https://doi.org/10.1136/bmj.p2493
Publication status	Published - 1 Nov 2023

Funding

Competing interests: We have read and understood BMJ policy on declaration of interests and declare that SM’s partner is employed by ICON, a global contract research organisation whose customers include many pharmaceutical companies. PO’s former PhD student was supported by a grant from Sigma Pharmaceuticals, which is a UK wholesaler and distributor.

Funders
Sigma-Tau Pharmaceuticals

Access to Document

10.1136/bmj.p2493

Cite this

@article{d849338c0a3b43fd9c5b84aba8b8c982,

title = "Authors' reply to Fell",

author = "Shai Mulinari and Piotr Ozieranski",

year = "2023",

month = nov,

day = "1",

doi = "10.1136/bmj.p2493",

language = "English",

volume = "383",

pages = "2493",

journal = "BMJ (Clinical research ed.)",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

Authors' reply to Fell

Funding

Access to Document

Other files and links

Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations

Cite this

Authors' reply to Fell

Funding

Access to Document

Other files and links

Projects

Following the money: cross-national study of pharmaceutical industry payments to medical associations and patient organisations

Cite this